{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:59:58Z","timestamp":1788001198773,"version":"build-2784847793"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Intramural Research Program of the National Institute of Health (NIH), National CancerInstitute, Center for Cancer Research, Frederick, MD, U.S.A"},{"name":"Birla Institute of Technologyand Science, Pilani"},{"name":"Department of Pharmaceutics, National Institute of Pharmaceutical Education andResearch (NIPER)-Guwahati, Assam"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemistry and Physics of Lipids"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.chemphyslip.2020.105036","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T12:05:52Z","timestamp":1609848352000},"page":"105036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Role of stealth lipids in nanomedicine-based drug carriers"],"prefix":"10.1016","volume":"235","author":[{"given":"Mehak","family":"Rastogi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranendra Narayan","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Singhvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chemphyslip.2020.105036_bib0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijpharm.2012.08.030","article-title":"Multiple administration of PEG-coated liposomal oxaliplatin enhances its therapeutic efficacy: a possible mechanism and the potential for clinical application","volume":"438","author":"Abu Lila","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0015","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1016\/S0021-9258(17)40291-2","article-title":"Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol","volume":"252","author":"Abuchowski","year":"1977","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0020","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/01.RVI.0000175324.63304.25","article-title":"Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time","volume":"16","author":"Ahmed","year":"2005","journal-title":"J. Vasc. Interv. Radiol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0025","first-page":"51","article-title":"Polyethylene glycol-coated biocompatible surfaces","author":"Alcantar","year":"2000","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0030","doi-asserted-by":"crossref","DOI":"10.1039\/C7RA04038E","article-title":"In vitro - In vivo and pharmacokinetic evaluation of solid lipid nanoparticles of furosemide using GastroplusTM","volume":"7","author":"Ali","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0005-2736(91)90246-5","article-title":"Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo","volume":"1066","author":"Allen","year":"1991","journal-title":"BBA - Biomembranes"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0040","series-title":"The Occurrence, Induction, Specificity and Potential Effect of Antibodies Against Poly(ethylene Glycol)","first-page":"147","author":"Armstrong","year":"2009"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0050","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0378-5173(02)00703-2","article-title":"Circulation and biodistribution profiles of long-circulating PEG-liposomes of various sizes in rabbits","volume":"253","author":"Awasthi","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.103.060228","article-title":"Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)-distearoylphosphatidylethanolamine on distribution and circulation kinetics","volume":"309","author":"Awasthi","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3844\/ajptsp.2007.98.105","article-title":"Insertion of poly (ethylene glycol)-lipid reduces the liposome-encapsulated hemoglobin-induced thrombocytopenic reaction","volume":"2","author":"Awasthi","year":"2007","journal-title":"Am. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3844\/ajptsp.2007.98.105","article-title":"Insertion of poly (ethylene glycol)-lipid reduces the liposome-encapsulated hemoglobin-induced thrombocytopenic reaction","volume":"2","author":"Awasthi","year":"2007","journal-title":"Am. J. Pharmacol. Toxicol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/S1359-0294(00)00090-X","article-title":"Liposome application: problems and prospects","author":"Barenholz","year":"2001","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae - the first FDA-approved nano-drug: lessons learned","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0080","series-title":"Cardiovascular Toxicology","first-page":"72","article-title":"Cardiac safety of liposomal anthracyclines","author":"Batist","year":"2007"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/0169-409X(95)00027-5","article-title":"Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery","author":"Bedu-Addo","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0301-4622(01)00201-0","article-title":"Lipid chain length effect on the phase behaviour of PCs\/PEG:2000-PEs mixtures. A spin label electron spin resonance and spectrophotometric study","volume":"93","author":"Belsito","year":"2001","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0095","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1039\/b804933e","article-title":"Polymer-supported lipid shells, onions, and flowers","volume":"4","author":"Bershteyn","year":"2008","journal-title":"Soft Matter"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0100","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/bc800239b","article-title":"Cytoplasmic delivery of liposomal contents mediated by an acid-labile cholesterol-vinyl ether-PEG conjugate","volume":"20","author":"Boomer","year":"2009","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0105","doi-asserted-by":"crossref","DOI":"10.1517\/13543780903114168","article-title":"Clinical overview on LipoplatinTM: A successful liposomal formulation of cisplatin","author":"Boulikas","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0110","first-page":"3031","article-title":"Systemic lipoplatin infusion results in preferential tumor uptake in human studies","volume":"25","author":"Boulikas","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0115","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1021\/nl103264u","article-title":"Sizing nanomatter in biological fluids by fluorescence single particle tracking","volume":"10","author":"Braeckmans","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3109\/10611860008997901","article-title":"Tc-99m-PEG-Liposomes for the evaluation of colitis in Crohn\u2019s disease","volume":"8","author":"Brouwers","year":"2000","journal-title":"J. Drug Target."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0125","first-page":"12","article-title":"Protein adsorption: a feasible method for nanoparticle functionalization?","author":"Cagliani","year":"2019","journal-title":"Materials Basel (Basel)"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0009-3084(01)00178-5","article-title":"Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics","volume":"113","author":"Carrion","year":"2001","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0135","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1039\/B606930D","article-title":"The chemical modification of liposome surfaces via a copper-mediated [3 + 2] azide-alkyne cycloaddition monitored by a colorimetric assay","author":"Cavalli","year":"2006","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0140","doi-asserted-by":"crossref","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","author":"Cerutti","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0145","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil\u00ae): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0150","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1124\/jpet.103.053413","article-title":"Multiple injections of pegylated liposomal doxorubicin: pharmacokinetics and therapeutic activity","volume":"306","author":"Charrois","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0155","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1021\/bc990147j","article-title":"Efficient clearance of poly(ethylene glycol)-Modified immunoenzyme with Anti-PEG monoclonal antibody for prodrug Cancer therapy","volume":"11","author":"Cheng","year":"2000","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0160","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.colsurfb.2011.02.033","article-title":"Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles","volume":"85","author":"Cheow","year":"2011","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0165","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1081\/DIS-120021803","article-title":"Surface modification of functional nanoparticles for controlled drug delivery","volume":"24","author":"Choi","year":"2003","journal-title":"J. Dispers. Sci. Technol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0170","article-title":"A tale of the two PEGylated liposomal doxorubicins","author":"Chou","year":"2015","journal-title":"Onco. Ther."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0175","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/ac902548m","article-title":"Measurement of poly(ethylene glycol) by cell-based anti-poly(ethylene glycol) ELISA","volume":"82","author":"Chuang","year":"2010","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1021\/mp8001254","article-title":"Controlled surface modification with poly(ethylene)glycol enhances diffusion of PLGA nanoparticles in human cervical Mucus","volume":"6","author":"Cu","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0185","first-page":"292","article-title":"Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes","author":"Dams","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2014.01.013","article-title":"Structure and kinetics of lipid-nucleic acid complexes","author":"Dan","year":"2014","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?","author":"Danhier","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0200","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1042\/BSR20090104","article-title":"Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics","volume":"30","author":"Deniz","year":"2010","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0210","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1158\/1078-0432.CCR-06-2443","article-title":"Pulsed-high intensity focused ultrasound and low temperature - Sensitive liposomes for enhanced targeted drug delivery and antitumor effect","volume":"13","author":"Dromi","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0215","doi-asserted-by":"crossref","DOI":"10.1002\/jps.21358","article-title":"Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development","author":"Drummond","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0220","doi-asserted-by":"crossref","DOI":"10.1038\/nrneph.2013.42","article-title":"Anaemia: the safety and efficacy of peginesatide in patients with CKD","author":"Eckardt","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/08982100802673940","article-title":"The encapsulation and release of guanosine from PEGylated liposomes","volume":"19","author":"Er","year":"2009","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0230","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1021\/bc3005057","article-title":"Quantitative evaluation of bioorthogonal chemistries for surface functionalization of nanoparticles","volume":"23","author":"Feldborg","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0235","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1126\/science.223.4639.888","article-title":"Polymerized surfactant vesicles: novel membrane mimetic systems","volume":"223","author":"Fendler","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0240","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.2147\/IJN.S111736","article-title":"Stealth, biocompatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studies","volume":"11","author":"Freag","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0245","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082331","article-title":"Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)","volume":"9","author":"Gaillard","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0255","first-page":"8","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","author":"Ganson","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0260","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jaci.2015.10.034","article-title":"Pre-existing anti-polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer","volume":"137","author":"Ganson","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0265","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1517\/17425247.2012.720969","article-title":"Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents","volume":"9","author":"Garay","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0270","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2217\/fon.13.146","article-title":"Liposomal chemotherapeutics","volume":"9","author":"Gentile","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0275","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1021\/ar300048p","article-title":"Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges","volume":"45","author":"Gomes-Da-Silva","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0927-7765(99)00156-3","article-title":"\u201cStealth\u201d corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption","volume":"18","author":"Gref","year":"2000","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0290","first-page":"3","article-title":"Preparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors","volume":"13","author":"Haeri","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0295","first-page":"3","article-title":"Preparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors","volume":"13","author":"Haeri","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0300","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1023\/A:1011199028318","article-title":"Phase I-II study of pegylated liposomal cisplatin (SPI-077TM) in patients with inoperable head and neck cancer","volume":"12","author":"Harrington","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0305","first-page":"3669","article-title":"Poly(lactic acid)-Poly(ethylene oxide) (PLA-PEG) nanoparticles: NMR studies of the central solidlike PLA core and the liquid PEG corona","volume":"18","author":"Heald","year":"2002","journal-title":"ACS Publications"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0310","first-page":"280","volume":"Vol 112","author":"Heyes","year":"2006"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0315","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1023\/B:PHAM.0000045229.87844.21","article-title":"Novel long-circulating lipid nanocapsules","volume":"21","author":"Hoarau","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0320","series-title":"Biomaterials Science An Introduction to Materials in Medicine","author":"Hoffman","year":"2013"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0325","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/bm901123j","article-title":"Hyperbranched polyglycerol-based lipids via oxyanionic polymerization: toward multifunctional stealth liposomes","volume":"11","author":"Hofmann","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0330","first-page":"4648","article-title":"Rapid access to Polyfunctional Lipids with complex architecture via oxyanionic ring-opening polymerization","volume":"44","author":"Hofmann","year":"2011","journal-title":"ACS Publications"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0335","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3390\/ijms11020754","article-title":"Lipid vesicle aggregation induced by cooling","volume":"11","author":"Howard","year":"2010","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0340","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003651","article-title":"Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile","volume":"4","author":"Hrkach","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0345","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jjco\/hyr017","article-title":"Phase II study of belotecan (CKD 602) as a single agent in patients with recurrent or progressive carcinoma of uterine cervix","volume":"41","author":"Hwang","year":"2011","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics3010001","article-title":"Anti-PEG IgM response against PEGylated liposomes in mice and rats","volume":"3","author":"Ichihara","year":"2010","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0355","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0142-9612(87)90099-8","article-title":"Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages","volume":"8","author":"Illum","year":"1987","journal-title":"Biomaterials"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0360","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0365","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1248\/bpb.b13-00107","article-title":"Anti-polyethyleneglycol antibody response to PEGylated substances","volume":"36","author":"Ishida","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0370","doi-asserted-by":"crossref","DOI":"10.1023\/A:1020134521778","article-title":"Liposome clearance","author":"Ishida","year":"2002","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0168-3659(02)00462-5","article-title":"Accelerated clearance of PEGylated liposomes in rats after repeated injections","volume":"88","author":"Ishida","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0380","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2005.04.003","article-title":"Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes","volume":"105","author":"Ishida","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2006.08.017","article-title":"Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0390","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jconrel.2006.08.001","article-title":"Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0395","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2007.05.015","article-title":"PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner","volume":"122","author":"Ishida","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0400","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2007.11.009","article-title":"The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats","volume":"126","author":"Ishida","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0405","article-title":"Fluorescence-based method for sensitive and rapid estimation of chlorin e6 in stealth liposomes for photodynamic therapy against Cancer","volume":"244","author":"Jain","year":"2020","journal-title":"Spectrochim. Acta A. Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0410","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.131202998","article-title":"How the immune system works to protect the host from infection: a personal view","volume":"98","author":"Janeway","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0415","doi-asserted-by":"crossref","unstructured":"Jeon, S., Science, J.A.-J. of C. and I., 1991, undefined, n.d. Protein\u2014surface interactions in the presence of polyethylene oxide: II. Effect of protein size. Elsevier.","DOI":"10.1016\/0021-9797(91)90044-9"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0021-9797(91)90043-8","article-title":"Protein\u2014surface interactions in the presence of polyethylene oxide","volume":"142","author":"Jeon","year":"1991","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0425","unstructured":"Jonge, M. de, Slingerland, M., W.L.-E.J. of, 2010, undefined, n.d. Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation. Elsevier."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0430","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.biomaterials.2007.11.030","article-title":"Hydrophobically derivatized hyperbranched polyglycerol as a human serum albumin substitute","volume":"29","author":"Kainthan","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0435","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/nl801736q","article-title":"Microfluidic platform for controlled synthesis of polymeric nanoparticles","volume":"8","author":"Karnik","year":"2008","journal-title":"Nano Lett."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0440","article-title":"Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol)","author":"Kenworthy","year":"1995","journal-title":"Biophys. J."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0445","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0169-5002(01)00278-1","article-title":"A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer","volume":"34","author":"Kim","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0450","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/bj1860591","article-title":"Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro","volume":"186","author":"Kirby","year":"1980","journal-title":"Biochem. J."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0455","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijpharm.2008.06.004","article-title":"Particle size-dependent triggering of accelerated blood clearance phenomenon","volume":"362","author":"Koide","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0460","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.281.5373.78","article-title":"An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery","volume":"281","author":"Koltover","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0465","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1039\/c2ob27199k","article-title":"A photo-triggerable drug carrier based on cleavage of PEG lipids by photosensitiser-generated reactive singlet oxygen","volume":"11","author":"Komeda","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0470","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/08982104.2014.891233","article-title":"Sterically stabilized liposomes as a potent carrier for shikonin","volume":"24","author":"Kontogiannopoulos","year":"2014","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0475","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/c0cc00784f","article-title":"\u201cClickable\u201d, polymerized liposomes as a versatile and stable platform for rapid optimization of their peripheral compositions","volume":"46","author":"Kumar","year":"2010","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0480","doi-asserted-by":"crossref","first-page":"6944","DOI":"10.1158\/1078-0432.CCR-05-0343","article-title":"Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors","volume":"11","author":"Laginha","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0485","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0014-5793(92)80947-F","article-title":"Gelation of liposome interior A novel method for drug encapsulation","volume":"312","author":"Lasic","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0490","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0005-2736(95)00159-Z","article-title":"Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery","volume":"1239","author":"Lasic","year":"1995","journal-title":"BBA - Biomembranes"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0495","first-page":"298","article-title":"Factors Affecting the Accelerated Blood Clearance of Polyethylene Glycol-Liposomes upon Repeated Injection","author":"Laverman","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0500","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejps.2016.08.058","article-title":"PEGylation of lipoplexes: the right balance between cytotoxicity and siRNA effectiveness","volume":"93","author":"Lechanteur","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0505","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/j.bbamem.2009.06.022","article-title":"Nanoparticles evading the reticuloendothelial system: role of the supported bilayer","volume":"1788","author":"Li","year":"2009","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0510","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jconrel.2010.03.016","article-title":"Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting","volume":"145","author":"Li","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0515","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0005-2736(98)00175-8","article-title":"Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient","volume":"1415","author":"Li","year":"1998","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0520","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.2042-7158.2010.01227.x","article-title":"Encapsulation of vinorelbine into cholesterol-polyethylene glycol coated vesicles: drug loading and pharmacokinetic studies","volume":"63","author":"Li","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0525","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(13)61841-3","article-title":"Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial","volume":"384","author":"Longo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0530","series-title":"Nonphospholipid Liposomes: Properties and Potential Use in Flavor Encapsulation.","first-page":"219","author":"Mathur","year":"1997"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0535","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","article-title":"Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein","volume":"12","author":"Mima","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0540","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1078\/0171-9335-00363","article-title":"PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles","volume":"83","author":"Mishra","year":"2004","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2018.05.021","article-title":"Lipid based nanocarriers: a translational perspective","author":"Mishra","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0550","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1096\/fj.06-6186fje","article-title":"Methylation of the phosphate oxygen moiety of phospholipid\u2010methoxy(polyethylene glycol) conjugate prevents PEGylated liposome\u2010mediated complement activation and anaphylatoxin production","volume":"20","author":"MoeinMoghimi","year":"2006","journal-title":"Faseb J."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0555","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/S0142-9612(01)00043-6","article-title":"Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules","volume":"22","author":"Mosqueira","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0560","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2013.02.026","article-title":"Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo","volume":"446","author":"Nag","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0565","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jps.24254","article-title":"Liposomes modified with superhydrophilic polymer linked to a nonphospholipid anchor exhibit reduced complement activation and enhanced circulation","volume":"104","author":"Nag","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0570","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jpba.2005.12.028","article-title":"Comparison of electrospray ionization mass spectrometry and evaporative light scattering detections for the determination of Poloxamer 188 in itraconazole injectable formulation","volume":"41","author":"Nair","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0575","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08982104.2016.1259628","article-title":"Ethanol-based proliposome delivery systems of paclitaxel for in vitro application against brain cancer cells","volume":"28","author":"Najlah","year":"2018","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11110610","article-title":"Development of injectable PEGylated liposome encapsulating disulfiram for colorectal cancer treatment","volume":"11","author":"Najlah","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0585","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.bbamem.2012.06.019","article-title":"Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods","volume":"1818","author":"Nakamura","year":"2012","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0590","first-page":"4","article-title":"A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue","author":"Nance","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0595","doi-asserted-by":"crossref","DOI":"10.1016\/S0169-409X(97)00135-X","article-title":"Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions","author":"Papisov","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0600","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/bcr432","article-title":"Liposome-based drug delivery in breast cancer treatment","volume":"4","author":"Park","year":"2002","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0605","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/14737140.2016.1192471","article-title":"The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy","volume":"16","author":"Passero","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0610","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejpb.2008.04.018","article-title":"Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: formulation development and in vitro anticancer activity","volume":"70","author":"Pulkkinen","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0615","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0620","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000233309","article-title":"Antibodies against polyethylene glycol produced in animals by immunization with monomethoxy polyethylene glycol modified proteins","volume":"70","author":"Richter","year":"1983","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0625","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000233512","article-title":"Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors","volume":"74","author":"Richter","year":"1984","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0630","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1021\/bc960039m","article-title":"Natural peptides as building blocks for the synthesis of large protein- like molecules with hydrazone and oxime linkages","volume":"7","author":"Rose","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0635","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12668-019-00680-6","article-title":"In vitro and in vivo assessment of designed melphalan loaded stealth solid lipid nanoparticles for parenteral delivery","volume":"10","author":"Rudhrabatla","year":"2020","journal-title":"BioNanoScience"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0640","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0645","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1081\/LPR-120020318","article-title":"Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes","volume":"13","author":"Sadzuka","year":"2003","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0650","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(03)00248-7","article-title":"Study on the characterization of mixed polyethyleneglycol modified liposomes containing doxorubicin","volume":"91","author":"Sadzuka","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0655","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.molimm.2013.07.014","article-title":"Selectivity of binding of PEGs and PEG-like oligomers to anti-PEG antibodies induced by methoxyPEG-proteins","volume":"57","author":"Saifer","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0660","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1042\/bj20020590","article-title":"Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions","volume":"366","author":"Shi","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0665","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0378-5173(00)00466-X","article-title":"Determination of incorporated amounts of poly(ethylene glycol)-derivatized lipids in liposomes for the physicochemical characterization of stealth liposomes","volume":"203","author":"Shimada","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0670","doi-asserted-by":"crossref","unstructured":"Shimizu, T., Ichihara, M., Yoshioka, Y., Ishida, T., Nakagawa, S., Kiwada, H., 1336. Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response, Biol. Pharm. Bull.","DOI":"10.1248\/bpb.b12-00276"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0675","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.imbio.2012.08.274","article-title":"Transport of PEGylated liposomes from the splenic marginal zone to the follicle in the induction phase of the accelerated blood clearance phenomenon","volume":"218","author":"Shimizu","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0680","doi-asserted-by":"crossref","unstructured":"Shiraishi, K., Hamano, M., Ma, H., K.K.-J. of controlled, 2013, undefined, n.d. Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. Elsevier.","DOI":"10.1016\/j.jconrel.2012.11.016"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0685","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/chem.200306073","article-title":"Self-assembled monolayers of dendritic polyglycerol derivatives on gold that resist the adsorption of proteins","volume":"10","author":"Siegers","year":"2004","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0690","doi-asserted-by":"crossref","first-page":"47615","DOI":"10.1074\/jbc.M106199200","article-title":"Molecular shape of the cationic lipid controls the structure of cationic Lipid\/Dioleylphosphatidylethanolamine-DNA complexes and the efficiency of gene delivery","volume":"276","author":"\u0160misterov\u00e1","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0695","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00396-003-1015-x","article-title":"Effect of a PEG lipid (DSPE-PEG2000) and freeze-thawing process on phospholipid vesicle size and lamellarity","volume":"282","author":"Sriwongsitanont","year":"2004","journal-title":"Colloid Polym. Sci."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0700","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/bc100067t","article-title":"Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies","volume":"21","author":"Su","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0705","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/mp100390w","article-title":"In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles","volume":"8","author":"Su","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0710","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1248\/bpb.30.208","article-title":"Characterization of novel mixed polyethyleneglycol modified liposomes","volume":"30","author":"Sugiyama","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0715","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2174\/157016311798109344","article-title":"Correlation of fixed aqueous layer thickness around PEG-modified liposomes with in vivo efficacy of antitumor agent-containing liposomes","volume":"8","author":"Sugiyama","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0720","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijpharm.2012.11.032","article-title":"Enhanced antitumor activity of different double arms polyethyleneglycol- modified liposomal doxorubicin","volume":"441","author":"Sugiyama","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0725","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1248\/bpb.b13-00084","article-title":"Change in the character of liposomes as a drug carrier by modifying various polyethyleneglycol-lipids","volume":"36","author":"Sugiyama","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0730","first-page":"14","article-title":"Effect of liposomes with different double arms polyethyleneglycol on hepatic metastasis model mice and evaluation using a fluorescent imaging device","author":"Sugiyama","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0735","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/art.22403","article-title":"Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout","volume":"56","author":"Sundy","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2005.07.023","article-title":"Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity","author":"Szebeni","year":"2005","journal-title":"Toxicology."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.molimm.2014.06.038","article-title":"Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals","author":"Szebeni","year":"2014","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0750","doi-asserted-by":"crossref","DOI":"10.1080\/08982100902792855","article-title":"Liposome triggering of innate immune responses: a perspective on benefits and adverse reactions","author":"Szebeni","year":"2009","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0755","first-page":"467","article-title":"The role of complement activation in hypersensitivity to pegylated liposomal Doxorubicin (Doxil\u00ae), in: journal of Liposome Research","author":"Szebeni","year":"2000","journal-title":"Marcel Dekker Inc."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0760","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nano.2011.06.003","article-title":"Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome","volume":"8","author":"Szebeni","year":"2012","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0765","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2009.04.006","article-title":"Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production","volume":"137","author":"Tagami","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0770","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2010.12.013","article-title":"Anti-PEG IgM production by siRNA encapsulated in a PEGylated lipid nanocarrier is dependent on the sequence of the siRNA","volume":"151","author":"Tagami","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0775","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1124\/dmd.109.028852","article-title":"Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice","volume":"37","author":"Taguchi","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0780","doi-asserted-by":"crossref","DOI":"10.3109\/02652049809006831","article-title":"Polymer-coated long-circulating microparticulate pharmaceuticals","author":"Torchilin","year":"1998","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/fluids3020036","article-title":"Comparative study of pEgylated and conventional liposomes as carriers for shikonin","volume":"3","author":"Tsermentseli","year":"2018","journal-title":"Fluids"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0790","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0192-0561(85)90158-4","article-title":"Studies on antigenicity of the polyethylene glycol (PEG)-modified uricase","volume":"7","author":"Tsuji","year":"1985","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0795","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-5793(96)00452-8","article-title":"Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time","volume":"386","author":"Uster","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0800","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.nano.2018.07.006","article-title":"Design and biological activity of novel stealth polymeric lipid nanoparticles for enhanced delivery of hydrophobic photodynamic therapy drugs","volume":"14","author":"Viard","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0805","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1081\/BIO-120023160","article-title":"Encapsulating protein into preformed liposomes by ethanol\u2010destabilized method","volume":"31","author":"Wang","year":"2003","journal-title":"Artif. Cells Blood Substit. Biotechnol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0810","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0815","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0005-2736(98)00077-7","article-title":"Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine","volume":"1372","author":"Webb","year":"1998","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0820","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1021\/acsomega.7b01235","article-title":"Cardinal role of intraliposome doxorubicin-sulfate nanorod crystal in doxil properties and performance","volume":"3","author":"Wei","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0825","article-title":"Sterically stabilized liposomes","author":"Woodle","year":"1992","journal-title":"BBA - Reviews on Biomembranes."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0830","doi-asserted-by":"crossref","DOI":"10.1021\/ja983183m","article-title":"Nanometer gold clusters protected by surface-bound monolayers of thiolated poly(ethylene glycol) polymer electrolyte [16]","author":"Wuelfing","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0835","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/nn2038516","article-title":"Quantifying the coverage density of poly(ethylene glycol) chains on the surface of gold nanostructures","volume":"6","author":"Xia","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0840","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2005.01.008","article-title":"Influence of the physicochemical properties of liposomes on the accelerated blood clearance phenomenon in rats","volume":"104","author":"Xin","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0845","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jconrel.2008.05.009","article-title":"Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives","volume":"130","author":"Xu","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0850","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1016\/j.biomaterials.2010.02.049","article-title":"Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes","volume":"31","author":"Xu","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0855","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jconrel.2013.05.035","article-title":"Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucus","volume":"170","author":"Xu","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0860","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3109\/10717544.2014.885998","article-title":"Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection","volume":"22","author":"Xu","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0865","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0870","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1002\/anie.201006849","article-title":"Biodegradable nanoparticles composed entirely of safe materials that rapidly penetrate human mucus","volume":"50","author":"Yang","year":"2011","journal-title":"AngewandteChemie - International Edition"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0875","first-page":"1257","article-title":"Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy","volume":"8","author":"Yang","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0880","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/adhm.201300519","article-title":"Vaginal delivery of paclitaxel via nanoparticles with non-mucoadhesive surfaces suppresses cervical tumor growth","volume":"3","author":"Yang","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0885","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/02656731003789284","article-title":"Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours","volume":"26","author":"Yarmolenko","year":"2010","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0890","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.colsurfa.2012.01.035","article-title":"Novel analytical method to evaluate the surface condition of polyethylene glycol-modified liposomes","volume":"397","author":"Yoshino","year":"2012","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0895","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1248\/bpb.19.1347","article-title":"Prolongation of liposome circulation time by various derivatives of polyethyleneglycols","volume":"19","author":"Yuda","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0900","doi-asserted-by":"crossref","unstructured":"Zabaleta, V., Campanero, M., and, J.I.-J. of pharmaceutical, 2007, undefined, n.d. An HPLC with evaporative light scattering detection method for the quantification of PEGs and Gantrez in PEGylated nanoparticles. Elsevier.","DOI":"10.1016\/j.jpba.2007.05.006"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0905","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1021\/bc00022a008","article-title":"Synthesis of an end-group functionalized polyethylene glycol-lipid conjugate for preparation of polymer-grafted liposomes","volume":"4","author":"Zalipsky","year":"1993","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0910","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/bc00032a002","article-title":"Functionalized poly(Ethylene glycols) for preparation of biologically relevant conjugates","volume":"6","author":"Zalipsky","year":"1995","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0915","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1158\/1078-0432.CCR-07-1035","article-title":"Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts","volume":"13","author":"Zamboni","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0920","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0005-2736(96)00167-8","article-title":"Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines","volume":"1285","author":"Zeisig","year":"1996","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0925","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1021\/nn800275r","article-title":"Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform","volume":"2","author":"Zhang","year":"2008","journal-title":"ACS Nano"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0930","first-page":"5503","article-title":"Effects of pegylated lipid nanoparticles on the oral absorption of one bcs ii drug: a mechanistic investigation","volume":"9","author":"Zhang","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0935","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejpb.2012.04.023","article-title":"A frustrating problem: accelerated blood clearance of PEGylated solid lipid nanoparticles following subcutaneous injection in rats","volume":"81","author":"Zhao","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.chemphyslip.2020.105036_bib0940","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1021\/ac062135e","article-title":"Method for quantifying the PEGylation of gelatin nanoparticle drug carrier systems using asymmetrical flow field-flow fractionation and refractive index detection","volume":"79","author":"Zillies","year":"2007","journal-title":"Anal. Chem."}],"container-title":["Chemistry and Physics of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308420301675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009308420301675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:58:41Z","timestamp":1762113521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009308420301675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":188,"alternative-id":["S0009308420301675"],"URL":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.105036","relation":{},"ISSN":["0009-3084"],"issn-type":[{"value":"0009-3084","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of stealth lipids in nanomedicine-based drug carriers","name":"articletitle","label":"Article Title"},{"value":"Chemistry and Physics of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.105036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105036"}}